SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 0.82 |
| Enterprise Value ($M) | 4.60 |
| Book Value ($M) | -3.83 |
| Book Value / Share | -0.45 |
| Price / Book | -0.21 |
| NCAV ($M) | -10.86 |
| NCAV / Share | -1.28 |
| Price / NCAV | -0.08 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -189.97 |
| Return on Assets (ROA) | -0.88 |
| Return on Equity (ROE) | -1.49 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.05 |
| Current Ratio | 0.18 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.81 |
| Assets | 8.84 |
| Liabilities | 12.67 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2.16 |
| Operating Income | -10.05 |
| Net Income | -32.28 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -1.50 |
| Cash from Investing | 0.02 |
| Cash from Financing | 1.49 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Halo Collective Inc. | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,139,425 | 12,569,654 | 17.02 | |
| 3,206,664 | 1,562,101 | 205.28 | |
| 27,662,144 | 8,788,038 | 314.77 | |
| 6,863,848 | 1,126,842 | 609.12 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AEZS – Aeterna Zentaris Inc. | AGEN – Agenus Inc. |
| AIMD – Ainos, Inc. | AKBA – Akebia Therapeutics, Inc. |
| ALBT – Avalon GloboCare Corp. |
Financial data and stock pages provided by
Fintel.io